Global Contrast Injector Market size is expected to reach US$ 2.66 Bn. by year 2029 at a CAGR of 7.34% during the forecast period.Contrast Injector Market Overview
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report High prevalence of cardiovascular & neurological disorders, a large number of approvals for contrast agents in different geographies, and growing demand for minimally invasive surgeries are propelling the global market growth. The high cost of contrast media injectors, the side effects and allergic reactions associated with contrast agents are limiting the global market growth. Based on regions, the global market is divided into five main regions are America, Europe, Asia-pacific, Latin America and Middle East & Africa.
Segment Analysis
On the basis of product, the consumables segment is estimated to account for the largest share of the market owing to the recurring use of consumables in diagnostic procedures to maintain hygienic conditions. The consumables segment is further divided into injector heads, syringes, tubing, and other consumables. The injector systems segment is further divided into CT injector systems, MRI injector systems, and angiography injector systems. CT injector systems segment is expected to command the largest share of the market. The MRI injector systems segment is expected to grow at the highest CAGR during the forecast period. In the application segment, interventional cardiology is projected grow at the highest rate during the forecast period because of the rising prevalence of cardiac diseases, such as coronary artery disease, heart valve disease, increasing use of contrast agents in various diagnostic procedures & centers, and peripheral vascular disease High prevalence of cardiovascular & neurological disorders, a large number of approvals for contrast agents in different geographies, and growing demand for minimally invasive surgeries are propelling the global market growth. The high cost of contrast media injectors, the side effects and allergic reactions associated with contrast agents are limiting the global market growth. The key opportunity of the market is ongoing advancement in contrast media injectors.
Regional Analysis
Geographically, the Asia-Pacific region is growing with the highest CAGR during the forecast period due to the increase in the installation of medical imaging equipment and procedures. The growth of the contrast injector market in the Asia-Pacific region is attributed to economic growth, which is led to increased disposable income and consequently, increased the affordability of sophisticated imaging technology, increasing population of old people. Moreover, a large population base and growing geriatric population, which is more prone to cardiovascular and certain neurological disorders, would lead to a large potential patient base. The report provides a comprehensive analysis of the key players operating in the global contrast injector market such as Bracco S.p.A, Bayer AG, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd, Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.Contrast Injector Market Scope: Inquire before buying
Global Contrast Injector Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US$ 1.62 Bn. Forecast Period 2023 to 2029 CAGR: 7.34% Market Size in 2029: US$ 2.66 Bn. Segments Covered: by Product Injector Systems Consumables Accessories by Application Interventional Radiology Interventional Cardiology Radiology by End User Diagnostics Centers Clinics Hospitals Others Contrast Injector Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Contrast Injector Market Key Players
1. Bracco S.p.A 2. Bayer AG 3. Guerbet Group 4. Medtron AG 5. Ulrich GmbH & Co. KG 6. GE Healthcare 7. Shenzhen Seacrown Electromechanical Co., Ltd 8. Nemoto Kyorindo Co. Ltd. 9. Sino Medical- Device Technology Co., Ltd. 10. Vivid Imaging. Frequently Asked Questions: 1. Which region has the largest share in Global Contrast Injector Market? Ans: Asia-Pacific region holds the highest share in 2022. 2. What is the growth rate of Global Contrast Injector Market? Ans: The Global Contrast Injector Market is growing at a CAGR of 7.34% during forecasting period 2023-2029. 3. What is scope of the Global Contrast Injector market report? Ans: Global Contrast Injector Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Contrast Injector market? Ans: The important key players in the Global Contrast Injector Market are – Bracco S.p.A, Bayer AG, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd, Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., Vivid Imaging., and 5. What is the study period of this market? Ans: The Global Contrast Injector Market is studied from 2022 to 2029.
Global Contrast Injector Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Contrast Injectors Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. Global Contrast Injectors Market Analysis and Forecast 5.1. Global Contrast Injectors Market Analysis and Forecast 5.2. Global Contrast Injectors Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Contrast Injectors Market Analysis and Forecast, by Product 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Contrast Injectors Market Value Share Analysis, by Product 6.4. Global Contrast Injectors Market Size (US$ Mn) Forecast, by Product 6.5. Global Contrast Injectors Market Analysis, by Product 6.6. Global Contrast Injectors Market Attractiveness Analysis, by Product 7. Global Contrast Injectors Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Global Contrast Injectors Market Value Share Analysis, by Application 7.3. Global Contrast Injectors Market Size (US$ Mn) Forecast, by Application 7.4. Global Contrast Injectors Market Analysis, by Application 7.5. Global Contrast Injectors Market Attractiveness Analysis, by Application 8. Global Contrast Injectors Market Analysis and Forecast, by End User 8.1. Introduction and Definition 8.2. Global Contrast Injectors Market Value Share Analysis, by End User 8.3. Global Contrast Injectors Market Size (US$ Mn) Forecast, by End User 8.4. Global Contrast Injectors Market Analysis, by End User 8.5. Global Contrast Injectors Market Attractiveness Analysis, by End User 9. Global Contrast Injectors Market Analysis, by Region 9.1. Global Contrast Injectors Market Value Share Analysis, by Region 9.2. Global Contrast Injectors Market Size (US$ Mn) Forecast, by Region 9.3. Global Contrast Injectors Market Attractiveness Analysis, by Region 10. North America Contrast Injectors Market Analysis 10.1. Key Findings 10.2. North America Contrast Injectors Market Overview 10.3. North America Contrast Injectors Market Value Share Analysis, by Product 10.4. North America Contrast Injectors Market Forecast, by Product 10.4.1. Injector Systems 10.4.2. Consumables 10.4.3. Accessories 10.5. North America Contrast Injectors Market Value Share Analysis, by Application 10.6. North America Contrast Injectors Market Forecast, by Application 10.6.1. Interventional Radiology 10.6.2. Interventional Cardiology 10.6.3. Radiology 10.7. North America Contrast Injectors Market Value Share Analysis, by End User 10.8. North America Contrast Injectors Market Forecast, by End User 10.8.1. Diagnostics Centers 10.8.2. Clinics 10.8.3. Hospitals 10.8.4. Others 10.9. North America Contrast Injectors Market Value Share Analysis, by Country 10.10. North America Contrast Injectors Market Forecast, by Country 10.10.1. U.S. 10.10.2. Canada 10.11. North America Contrast Injectors Market Analysis, by Country 10.12. U.S. Contrast Injectors Market Forecast, by Product 10.12.1. Injector Systems 10.12.2. Consumables 10.12.3. Accessories 10.13. U.S. Contrast Injectors Market Forecast, by Application 10.13.1. Interventional Radiology 10.13.2. Interventional Cardiology 10.13.3. Radiology 10.14. U.S. Contrast Injectors Market Forecast, by End User 10.14.1. Diagnostics Centers 10.14.2. Clinics 10.14.3. Hospitals 10.14.4. Others 10.15. Canada Contrast Injectors Market Forecast, by Product 10.15.1. Injector Systems 10.15.2. Consumables 10.15.3. Accessories 10.16. Canada Contrast Injectors Market Forecast, by Application 10.16.1. Interventional Radiology 10.16.2. Interventional Cardiology 10.16.3. Radiology 10.17. Canada Contrast Injectors Market Forecast, by End User 10.17.1. Diagnostics Centers 10.17.2. Clinics 10.17.3. Hospitals 10.17.4. Others 10.18. North America Contrast Injectors Market Attractiveness Analysis 10.18.1. By Product 10.18.2. By Application 10.18.3. By End User 10.19. PEST Analysis 11. Europe Contrast Injectors Market Analysis 11.1. Key Findings 11.2. Europe Contrast Injectors Market Overview 11.3. Europe Contrast Injectors Market Value Share Analysis, by Product 11.4. Europe Contrast Injectors Market Forecast, by Product 11.4.1. Injector Systems 11.4.2. Consumables 11.4.3. Accessories 11.5. Europe Contrast Injectors Market Value Share Analysis, by Application 11.6. Europe Contrast Injectors Market Forecast, by Application 11.6.1. Interventional Radiology 11.6.2. Interventional Cardiology 11.6.3. Radiology 11.7. Europe Contrast Injectors Market Value Share Analysis, by End User 11.8. Europe Contrast Injectors Market Forecast, by End User 11.8.1. Diagnostics Centers 11.8.2. Clinics 11.8.3. Hospitals 11.8.4. Others 11.9. Europe Contrast Injectors Market Value Share Analysis, by Country 11.10. Europe Contrast Injectors Market Forecast, by Country 11.10.1. Germany 11.10.2. U.K. 11.10.3. France 11.10.4. Italy 11.10.5. Spain 11.10.6. Rest of Europe 11.11. Europe Contrast Injectors Market Analysis, by Country/ Sub-region 11.12. Germany Contrast Injectors Market Forecast, by Product 11.12.1. Injector Systems 11.12.2. Consumables 11.12.3. Accessories 11.13. Germany Contrast Injectors Market Forecast, by Application 11.13.1. Interventional Radiology 11.13.2. Interventional Cardiology 11.13.3. Radiology 11.14. Germany Contrast Injectors Market Forecast, by End User 11.14.1. Diagnostics Centers 11.14.2. Clinics 11.14.3. Hospitals 11.14.4. Others 11.15. U.K. Contrast Injectors Market Forecast, by Product 11.15.1. Injector Systems 11.15.2. Consumables 11.15.3. Accessories 11.16. U.K. Contrast Injectors Market Forecast, by Application 11.16.1. Interventional Radiology 11.16.2. Interventional Cardiology 11.16.3. Radiology 11.17. U.K. Contrast Injectors Market Forecast, by End User 11.17.1. Diagnostics Centers 11.17.2. Clinics 11.17.3. Hospitals 11.17.4. Others 11.18. France Contrast Injectors Market Forecast, by Product 11.18.1. Injector Systems 11.18.2. Consumables 11.18.3. Accessories 11.19. France Contrast Injectors Market Forecast, by Application 11.19.1. Interventional Radiology 11.19.2. Interventional Cardiology 11.19.3. Radiology 11.20. France Contrast Injectors Market Forecast, by End User 11.20.1. Diagnostics Centers 11.20.2. Clinics 11.20.3. Hospitals 11.20.4. Others 11.21. Italy Contrast Injectors Market Forecast, by Product 11.21.1. Injector Systems 11.21.2. Consumables 11.21.3. Accessories 11.22. Italy Contrast Injectors Market Forecast, by Application 11.22.1. Interventional Radiology 11.22.2. Interventional Cardiology 11.22.3. Radiology 11.23. Italy Contrast Injectors Market Forecast, by End User 11.23.1. Diagnostics Centers 11.23.2. Clinics 11.23.3. Hospitals 11.23.4. Others 11.24. Spain Contrast Injectors Market Forecast, by Product 11.24.1. Injector Systems 11.24.2. Consumables 11.24.3. Accessories 11.25. Spain Contrast Injectors Market Forecast, by Application 11.25.1. Interventional Radiology 11.25.2. Interventional Cardiology 11.25.3. Radiology 11.26. Spain Contrast Injectors Market Forecast, by End User 11.26.1. Diagnostics Centers 11.26.2. Clinics 11.26.3. Hospitals 11.26.4. Others 11.27. Rest of Europe Contrast Injectors Market Forecast, by Product 11.27.1. Injector Systems 11.27.2. Consumables 11.27.3. Accessories 11.28. Rest of Europe Contrast Injectors Market Forecast, by Application 11.28.1. Interventional Radiology 11.28.2. Interventional Cardiology 11.28.3. Radiology 11.29. Rest of Europe Contrast Injectors Market Forecast, by End User 11.29.1. Diagnostics Centers 11.29.2. Clinics 11.29.3. Hospitals 11.29.4. Others 11.30. Europe Contrast Injectors Market Attractiveness Analysis 11.30.1. By Product 11.30.2. By Application 11.30.3. By End User 11.31. PEST Analysis 12. Asia Pacific Contrast Injectors Market Analysis 12.1. Key Findings 12.2. Asia Pacific Contrast Injectors Market Overview 12.3. Asia Pacific Contrast Injectors Market Value Share Analysis, by Product 12.4. Asia Pacific Contrast Injectors Market Forecast, by Product 12.4.1. Injector Systems 12.4.2. Consumables 12.4.3. Accessories 12.5. Asia Pacific Contrast Injectors Market Value Share Analysis, by Application 12.6. Asia Pacific Contrast Injectors Market Forecast, by Application 12.6.1. Interventional Radiology 12.6.2. Interventional Cardiology 12.6.3. Radiology 12.7. Asia Pacific Contrast Injectors Market Value Share Analysis, by End User 12.8. Asia Pacific Contrast Injectors Market Forecast, by End User 12.8.1. Diagnostics Centers 12.8.2. Clinics 12.8.3. Hospitals 12.8.4. Others 12.9. Asia Pacific Contrast Injectors Market Value Share Analysis, by Country 12.10. Asia Pacific Contrast Injectors Market Forecast, by Country 12.10.1. China 12.10.2. India 12.10.3. Japan 12.10.4. ASEAN 12.10.5. Rest of Asia Pacific 12.11. Asia Pacific Contrast Injectors Market Analysis, by Country/ Sub-region 12.12. China Contrast Injectors Market Forecast, by Product 12.12.1. Injector Systems 12.12.2. Consumables 12.12.3. Accessories 12.13. China Contrast Injectors Market Forecast, by Application 12.13.1. Interventional Radiology 12.13.2. Interventional Cardiology 12.13.3. Radiology 12.14. China Contrast Injectors Market Forecast, by End User 12.14.1. Diagnostics Centers 12.14.2. Clinics 12.14.3. Hospitals 12.14.4. Others 12.15. India Contrast Injectors Market Forecast, by Product 12.15.1. Injector Systems 12.15.2. Consumables 12.15.3. Accessories 12.16. India Contrast Injectors Market Forecast, by Application 12.16.1. Interventional Radiology 12.16.2. Interventional Cardiology 12.16.3. Radiology 12.17. India Contrast Injectors Market Forecast, by End User 12.17.1. Diagnostics Centers 12.17.2. Clinics 12.17.3. Hospitals 12.17.4. Others 12.18. Japan Contrast Injectors Market Forecast, by Product 12.18.1. Injector Systems 12.18.2. Consumables 12.18.3. Accessories 12.19. Japan Contrast Injectors Market Forecast, by Application 12.19.1. Interventional Radiology 12.19.2. Interventional Cardiology 12.19.3. Radiology 12.20. Japan Contrast Injectors Market Forecast, by End User 12.20.1. Diagnostics Centers 12.20.2. Clinics 12.20.3. Hospitals 12.20.4. Others 12.21. ASEAN Contrast Injectors Market Forecast, by Product 12.21.1. Injector Systems 12.21.2. Consumables 12.21.3. Accessories 12.22. ASEAN Contrast Injectors Market Forecast, by Application 12.22.1. Interventional Radiology 12.22.2. Interventional Cardiology 12.22.3. Radiology 12.23. ASEAN Contrast Injectors Market Forecast, by End User 12.23.1. Diagnostics Centers 12.23.2. Clinics 12.23.3. Hospitals 12.23.4. Others 12.24. Rest of Asia Pacific Contrast Injectors Market Forecast, by Product 12.24.1. Injector Systems 12.24.2. Consumables 12.24.3. Accessories 12.25. Rest of Asia Pacific Contrast Injectors Market Forecast, by Application 12.25.1. Interventional Radiology 12.25.2. Interventional Cardiology 12.25.3. Radiology 12.26. Rest of Asia Pacific Contrast Injectors Market Forecast, by End User 12.26.1. Diagnostics Centers 12.26.2. Clinics 12.26.3. Hospitals 12.26.4. Others 12.27. Asia Pacific Contrast Injectors Market Attractiveness Analysis 12.27.1. By Product 12.27.2. By Application 12.27.3. By End User 12.28. PEST Analysis 13. Middle East & Africa Contrast Injectors Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Contrast Injectors Market Overview 13.3. Middle East & Africa Contrast Injectors Market Value Share Analysis, by Product 13.4. Middle East & Africa Contrast Injectors Market Forecast, by Product 13.4.1. Injector Systems 13.4.2. Consumables 13.4.3. Accessories 13.5. Middle East & Africa Contrast Injectors Market Value Share Analysis, by Application 13.6. Middle East & Africa Contrast Injectors Market Forecast, by Application 13.6.1. Interventional Radiology 13.6.2. Interventional Cardiology 13.6.3. Radiology 13.7. Middle East & Africa Contrast Injectors Market Value Share Analysis, by End User 13.8. Middle East & Africa Contrast Injectors Market Forecast, by End User 13.8.1. Diagnostics Centers 13.8.2. Clinics 13.8.3. Hospitals 13.8.4. Others 13.9. Middle East & Africa Contrast Injectors Market Value Share Analysis, by Country 13.10. Middle East & Africa Contrast Injectors Market Forecast, by Country 13.10.1. GCC 13.10.2. South Africa 13.10.3. Rest of Middle East & Africa 13.11. Middle East & Africa Contrast Injectors Market Analysis, by Country/ Sub-region 13.12. GCC Contrast Injectors Market Forecast, by Product 13.12.1. Injector Systems 13.12.2. Consumables 13.12.3. Accessories 13.13. GCC Contrast Injectors Market Forecast, by Application 13.13.1. Interventional Radiology 13.13.2. Interventional Cardiology 13.13.3. Radiology 13.14. GCC Contrast Injectors Market Forecast, by End User 13.14.1. Diagnostics Centers 13.14.2. Clinics 13.14.3. Hospitals 13.14.4. Others 13.15. South Africa Contrast Injectors Market Forecast, by Product 13.15.1. Injector Systems 13.15.2. Consumables 13.15.3. Accessories 13.16. South Africa Contrast Injectors Market Forecast, by Application 13.16.1. Interventional Radiology 13.16.2. Interventional Cardiology 13.16.3. Radiology 13.17. South Africa Contrast Injectors Market Forecast, by End User 13.17.1. Diagnostics Centers 13.17.2. Clinics 13.17.3. Hospitals 13.17.4. Others 13.18. Rest of Middle East & Africa Contrast Injectors Market Forecast, by Product 13.18.1. Injector Systems 13.18.2. Consumables 13.18.3. Accessories 13.19. Rest of Middle East & Africa Contrast Injectors Market Forecast, by Application 13.19.1. Interventional Radiology 13.19.2. Interventional Cardiology 13.19.3. Radiology 13.20. Rest of Middle East & Africa Contrast Injectors Market Forecast, by End User 13.20.1. Diagnostics Centers 13.20.2. Clinics 13.20.3. Hospitals 13.20.4. Others 13.21. Middle East & Africa Contrast Injectors Market Attractiveness Analysis 13.21.1. By Product 13.21.2. By Application 13.21.3. By End User 13.22. PEST Analysis 14. Latin America Contrast Injectors Market Analysis 14.1. Key Findings 14.2. Latin America Contrast Injectors Market Overview 14.3. Latin America Contrast Injectors Market Value Share Analysis, by Product 14.4. Latin America Contrast Injectors Market Forecast, by Product 14.4.1. Injector Systems 14.4.2. Consumables 14.4.3. Accessories 14.5. Latin America Contrast Injectors Market Value Share Analysis, by Application 14.6. Latin America Contrast Injectors Market Forecast, by Application 14.6.1. Interventional Radiology 14.6.2. Interventional Cardiology 14.6.3. Radiology 14.7. Latin America Contrast Injectors Market Value Share Analysis, by End User 14.8. Latin America Contrast Injectors Market Forecast, by End User 14.8.1. Diagnostics Centers 14.8.2. Clinics 14.8.3. Hospitals 14.8.4. Others 14.9. Latin America Contrast Injectors Market Value Share Analysis, by Country 14.10. Latin America Contrast Injectors Market Forecast, by Country 14.10.1. Brazil 14.10.2. Mexico 14.10.3. Rest of Latin America 14.11. Latin America Contrast Injectors Market Analysis, by Country/ Sub-region 14.12. Brazil Contrast Injectors Market Forecast, by Product 14.12.1. Injector Systems 14.12.2. Consumables 14.12.3. Accessories 14.13. Brazil Contrast Injectors Market Forecast, by Application 14.13.1. Interventional Radiology 14.13.2. Interventional Cardiology 14.13.3. Radiology 14.14. Brazil Contrast Injectors Market Forecast, by End User 14.14.1. Diagnostics Centers 14.14.2. Clinics 14.14.3. Hospitals 14.14.4. Others 14.15. Mexico Contrast Injectors Market Forecast, by Product 14.15.1. Injector Systems 14.15.2. Consumables 14.15.3. Accessories 14.16. Mexico Contrast Injectors Market Forecast, by Application 14.16.1. Interventional Radiology 14.16.2. Interventional Cardiology 14.16.3. Radiology 14.17. Mexico Contrast Injectors Market Forecast, by End User 14.17.1. Diagnostics Centers 14.17.2. Clinics 14.17.3. Hospitals 14.17.4. Others 14.18. Rest of Latin America Contrast Injectors Market Forecast, by Product 14.18.1. Injector Systems 14.18.2. Consumables 14.18.3. Accessories 14.19. Rest of Latin America Contrast Injectors Market Forecast, by Application 14.19.1. Interventional Radiology 14.19.2. Interventional Cardiology 14.19.3. Radiology 14.20. Rest of Latin America Contrast Injectors Market Forecast, by End User 14.20.1. Diagnostics Centers 14.20.2. Clinics 14.20.3. Hospitals 14.20.4. Others 14.21. Latin America Contrast Injectors Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By Application 14.21.3. By End User 14.22. PEST Analysis 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.3. Company Profiles: Key Players 15.3.1. Vivid Imaging 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Business Strategy 15.3.1.4. Recent Developments 15.3.1.5. Manufacturing Footprint 15.3.2. Bracco S.p.A 15.3.3. Bayer AG 15.3.4. Guerbet Group 15.3.5. Medtron AG 15.3.6. Ulrich GmbH & Co. KG 15.3.7. GE Healthcare 15.3.8. Shenzhen Seacrown Electromechanical Co., Ltd. 15.3.9. Nemoto Kyorindo Co. Ltd. 15.3.10. Sino Medical- Device Technology Co., Ltd. 16. Primary Key Insights